Objective. To evaluate the impact of continuous glucose monitoring (CGM) on quality of life (QOL) among persons with type 1 diabetes.
Research Design and Methods. In a multicenter trial, 451 children and adults with type 1 diabetes were randomly assigned to CGM treatment or the control group. Generic and diabetes-specific QOL questionnaires were completed by all participants and parents of participants <18 years at baseline and 26 weeks and the CGM Satisfaction scale by CGM group (participants and parents) at 26 weeks.
Results. After 26 weeks, QOL scores remained largely unchanged for both treatment and control groups, although there was a slight difference favoring the adult CGM group on several subscales (p <0.05). There was substantial satisfaction with CGM technology after 26 weeks among participants and parents.
Conclusions. Baseline QOL was high and the measures showed little change with CGM use, although a high level of CGM satisfaction was reported.
- Copyright © American Diabetes Association